Similar to IL‐37 treatment, administration of a single injection of IL‐37 plus TnI–treated tDCs in post‐MI mice significantly reduced the infiltration of inflammatory cells, ameliorated myocardial fibrosis, and improved cardiac function. The gene discussed is IL37; the disease is Myocardial fibrosis.